Latest News

Med Tech Dive reported that UB startup QAS.AI, founded by Ciprian Ionita, received one of the first grants awarded by Johnson & Johnson from a fund launched earlier this year to support the use of AI in surgery.

The Albany Times-Union and The Buffalo News reported that New York has created a $10 million fund for brain research on SUNY campuses, including research at UB, led by Jonathan Lovell, to build an Alzheimer’s vaccine. 

U.S. News & World Report has once again ranked UB among the nation’s top public colleges and universities.

Finding could improve predictions for wildfire smoke, extreme rainfall, pharmaceutical development and more.

The American Parkinsons Disease Association announced $4.04 million in new funding for cutting-edge Parkinson’s disease research, which includes support for Jonathan Lovell (BME), who is testing a new type of vaccine.

The advancement lays the groundwork for creating a library of sugar-recognizing proteins that may help detect and treat diverse illnesses.

Scientist Live reported on the The Coalition for Epidemic Preparedness Innovation awarding POP Biotechnologies, a UB startup co-founded by Jonathan Lovell, $1.5 million for research into making vaccines against epidemic and pandemic threats. 

The Coalition for Epidemic Preparedness Innovations (CEPI) reported that it will provide POP Biotechnologies, a UB startup co-founded by Jonathan Lovell), with $1.5 million for research into making vaccines against epidemic and pandemic threats.